Report LibraryAll Reports
Datamonitor Healthcare PharmaVitae: Roche Company Analysis
Retail Price: $3,000.00*BioMedTracker Subscriber Price: $2,100.00 - click here to log in
October 03, 2018PharmaVitae explores Roche’s prescription pharmaceutical performance and outlook, encompassing corporate strategy, marketed portfolio, pipeline potential, and financial performance over 2017–27.
This Datamonitor Healthcare report contains a PharmaVitae Company Analysis module.
|Disease Group Covered:||Not Specified|